Henryk Adrian Welp

Dr. Henryk Adrian Welp

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 May 2007 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
CEChristian D. Etz
Christian D. Etz
HWHenryk Adrian Welp
Henryk Adrian Welp
TTTony D.T. Tjan
Tony D.T. Tjan
AHAndreas Hoffmeier
Andreas Hoffmeier
EWErnst Weigang
Ernst Weigang
CSChristof Schmid
Christof Schmid

25 January 2010 in The Thoracic and Cardiovascular Surgeon
Verified
Journal Article
Closed access
PDF file
HWHenryk Adrian Welp
Henryk Adrian Welp
Andreas RukosujewAndreas Rukosujew
Andreas Rukosujew
TTT. D. T. Tjan
T. D. T. Tjan
AHA. Hoffmeier
A. Hoffmeier
VKV. Kösek
V. Kösek
GDG. Drees
G. Drees
Introduction: Left ventricular assist devices have been successfully used as a bridge to cardiac transplantation. Because many patients exhibit marked clinical improvement of their heart failure after LVAD implantation, we studied the physiological effect of pulsatile and non-pulsatile devices on the neurohormonal axis and exercise capacity. Methods: We prospectively included 20 patients (17 men, 3 women) undergoing LVAD implantation between November 2001 and January 2004. Ten patients (1 woman and 9 men) were treated with the non-pulsatile INCOR-LVAD (Berlin Heart©) and ten patients received the pulsatile EXCOR LVAD (Berlin Heart©). Blood samples for plasma renin activity (PRA) were taken once a week over a period of ten weeks. All blood samples were collected in the morning before mobilization. Blood pressure, body weight, fluid intake and urine production were measured once a day. All patients received standard hospital diet with no limitation in fluid intake. Results: Body weight remained constant in both groups throughout the ten weeks' examination, and fluid intake and urine production were balanced in all patients. Although there was no significant difference in mean blood pressure (INCOR: 70 ± 10 mmHg; EXCOR: 73 ± 10 mmHg), plasma renin activity was substantially elevated in patients with non-pulsatile left ventricular support (INCOR: 94.68 ± 33.97 µU/ml; EXCOR: 17.06 ± 15.94 µU/ml; p < 0.05). Furthermore plasma aldosterone levels were significantly higher in patients supported by non-pulsatile INCOR LVAD (INCOR: 73.4 ± 9.6 µg/ml; EXCOR: 20.6 ± 4.6 µg/ml; p < 0.05). Conclusions: Our data suggest that pulsatile as well as non-pulsatile left ventricular assist devices are equally able to treat chronic heart failure. However pulsatile devices seem to have a greater impact on reversing the changes in plasma renin activity and might thus offer a greater advantage when recovery of left ventricular function is expected.

1 July 2009 in Transplantation Proceedings
Verified
Journal Article
Closed access
HWHenryk Adrian Welp
Henryk Adrian Welp
TST. Spieker
T. Spieker
MEM. Erren
M. Erren
HSH.H. Scheld
H.H. Scheld
HBH.A. Baba
H.A. Baba
JSJ. Stypmann
J. Stypmann

21 September 2021 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
Matthias ThielmannMatthias Thielmann
Matthias Thielmann
DWDaniel Wendt
Daniel Wendt
ISIngo Slottosch
Ingo Slottosch
HWHenryk Adrian Welp
Henryk Adrian Welp
WSWolfgang Schiller
Wolfgang Schiller
OLOliver‐J. Liakopoulos
Oliver‐J. Liakopoulos
Background: Coronary artery bypass grafting has remained an important treatment option for acute coronary syndromes, particularly in patients (1) with ongoing ischemia and large areas of jeopardized myocardium, if percutaneous coronary intervention (PCI) cannot be performed; (2) following successful PCI of the culprit lesion with further indication for coronary artery bypass grafting; and (3) where PCI is incomplete, not sufficient, or failed. Methods and Results: We aimed to analyze coronary artery bypass grafting outcome following prior PCI in acute coronary syndromes from the North‐Rhine‐Westphalia surgical myocardial infarction registry comprising 2616 patients. Primary end points were in‐hospital all‐cause mortality and major adverse cardio‐cerebral event. Patients were 68±11 years of age, had 3‐vessel and left main‐stem disease in 80.4% and 45.3%, presenting a logistic EuroSCORE of 15.1% in unstable angina, 20.3% in non–ST‐segment–elevation myocardial infarction, and 23.5% in ST‐segment–elevation myocardial infarction. A history of PCI was present in 36.2% and PCI was performed within 24 hours before surgery in 5.2% in unstable angina, 5.9% in non–ST‐segment–elevation myocardial infarction, and 16.1% in ST‐segment–elevation myocardial infarction. PCI failed in 5.3% in unstable angina, 6.8% in non–ST‐segment–elevation myocardial infarction and 17.2% in ST‐segment–elevation myocardial infarction, and 28.8% of patients presented with cardiogenic shock. In‐hospital mortality without PCI was 7.4%, but increased to 8.7% with prior PCI >24 hours, 14.5% with prior PCI <24 hours, and 14.1% with failed PCI ( P 24 hours, 25.6% with prior PCI <24 hours, and 41.3% with failed PCI ( P =0.014). Multivariable logistic regression analysis showed prior PCI ( P =0.039), as well as failed PCI ( P =0.001) to be predictors for in‐hospital all‐cause mortality and major adverse cardio‐cerebral event. Conclusions: In the current PCI era, immediately prior or failed PCI before coronary artery bypass grafting in acute coronary syndromes is associated with high perioperative risk, cardiogenic shock, and increased morbidity and mortality.

14 December 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Fausto BiancariFausto Biancari
Fausto Biancari
Alexander KasererAlexander Kaserer
Alexander Kaserer
APAndrea Perrotti
Andrea Perrotti
VRVito G. Ruggieri
Vito G. Ruggieri
Sung-Min ChoSung-Min Cho
Sung-Min Cho
GMGiovanni Mariscalco
Giovanni Mariscalco
Background: It is unclear whether peripheral arterial cannulation is superior to central arterial cannulation for postcardiotomy veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Methods: A systematic review was conducted using PubMed, Scopus, and Google Scholar to identify studies on postcardiotomy VA-ECMO for the present individual patient data (IPD) meta-analysis. Analysis was performed according to the intention-to-treat principle. Results: The investigators of 10 studies agreed to participate in the present IPD meta-analysis. Overall, 1269 patients were included in the analysis. Crude rates of in-hospital mortality after central versus peripheral arterial cannulation for VA-ECMO were 70.7% vs. 63.7%, respectively (adjusted OR 1.38, 95% CI 1.08–1.75). Propensity score matching yielded 538 pairs of patients with balanced baseline characteristics and operative variables. Among these matched cohorts, central arterial cannulation VA-ECMO was associated with significantly higher in-hospital mortality compared to peripheral arterial cannulation VA-ECMO (64.5% vs. 70.8%, p = 0.027). These findings were confirmed by aggregate data meta-analysis, which showed that central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation (OR 1.35, 95% CI 1.04–1.76, I2 21%). Conclusions: Among patients requiring postcardiotomy VA-ECMO, central arterial cannulation was associated with an increased risk of in-hospital mortality compared to peripheral arterial cannulation. This increased risk is of limited magnitude, and further studies are needed to confirm the present findings and to identify the mechanisms underlying the potential beneficial effects of peripheral VA-ECMO.

1 June 2016 in Journal of Cardiothoracic and Vascular Anesthesia
Verified
Journal Article
Closed access
PDF file
HWHenryk Adrian Welp
Henryk Adrian Welp
JSJürgen R. Sindermann
Jürgen R. Sindermann
HDHeinz Deschka
Heinz Deschka
SMSven Martens
Sven Martens
MSMirela Scherer
Mirela Scherer